Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management.
Borea R, Favero D, Miceli A, Donegani MI, Raffa S, Gandini A, Cremante M, Marini C, Sambuceti G, Zanardi E, Morbelli S, Fornarini G, Rebuzzi SE, Bauckneht M. Borea R, et al. Among authors: gandini a. Diagnostics (Basel). 2022 Feb 24;12(3):581. doi: 10.3390/diagnostics12030581. Diagnostics (Basel). 2022. PMID: 35328134 Free PMC article. Review.
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.
Puccini A, Ponzano M, Dalmasso B, Vanni I, Gandini A, Puglisi S, Borea R, Cremante M, Bruno W, Andreotti V, Allavena E, Martelli V, Catalano F, Grassi M, Iaia ML, Pirrone C, Pastorino A, Fornarini G, Sciallero S, Ghiorzo P, Pastorino L. Puccini A, et al. Among authors: gandini a. Cancers (Basel). 2022 Sep 13;14(18):4447. doi: 10.3390/cancers14184447. Cancers (Basel). 2022. PMID: 36139606 Free PMC article.
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
Fornarini G, Rebuzzi SE, Buti S, Rescigno P, Merseburger A, Sternberg CN, de Giorgi U, Basso U, Maruzzo M, Giannatempo P, Ponzano M, Giunta EF, Catalano F, Murianni V, Damassi A, Cremante M, Gandini A, Puglisi S, Llaja Obispo MA, Signori A, Banna GL. Fornarini G, et al. Among authors: gandini a. Minerva Urol Nephrol. 2023 Jun;75(3):308-318. doi: 10.23736/S2724-6051.22.05135-7. Epub 2022 Dec 13. Minerva Urol Nephrol. 2023. PMID: 36511379 Free article. Clinical Trial.
Reliability of patient-reported toxicities during adjuvant chemotherapy.
Cremante M, Pastorino A, Ponzano M, Grassi M, Martelli V, Puccini A, Catalano F, Murianni V, Iaia ML, Puglisi S, Gandini A, Fornarini G, Caprioni F, Andretta V, Pessino A, Comandini D, Sciallero MS, Mammoliti S, Sormani MP, Sobrero A. Cremante M, et al. Among authors: gandini a. Eur J Cancer. 2023 Mar;182:115-121. doi: 10.1016/j.ejca.2023.01.005. Epub 2023 Jan 14. Eur J Cancer. 2023. PMID: 36758476
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
Giunta EF, De Padova S, Anpalakhan S, De Giorgi U, Maruzzo M, Rebuzzi SE, Cinausero M, Fratino L, Lipari H, Gamba T, Bimbatti D, Dri A, Ermacora P, Vignani F, Basso U, Buti S, Gandini A, Cremante M, Fornarini G, Rescigno P, Banna GL. Giunta EF, et al. Among authors: gandini a. Support Care Cancer. 2023 Jun 26;31(7):425. doi: 10.1007/s00520-023-07867-4. Support Care Cancer. 2023. PMID: 37358628
163 results